Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: a multicentre retrospective analysis
dc.contributor.author | Gillessen, Silke | |
dc.contributor.author | Schmid, S | |
dc.contributor.author | Beltran, H | |
dc.contributor.author | Almeida, D | |
dc.contributor.author | Mehra, N | |
dc.contributor.author | Lavaud, P | |
dc.contributor.author | Barrera, R | |
dc.contributor.author | Pignataro, D | |
dc.contributor.author | Marcos, E | |
dc.contributor.author | Conteduca, V | |
dc.contributor.author | Efstathiou, E | |
dc.contributor.author | Le, HML | |
dc.contributor.author | Pezaro, C | |
dc.contributor.author | Suzuki, H | |
dc.contributor.author | Zivi, A | |
dc.contributor.author | Klingbiel, D | |
dc.contributor.author | Omlin, A | |
dc.date.accessioned | 2019-04-29T09:49:01Z | |
dc.date.available | 2019-04-29T09:49:01Z | |
dc.date.issued | 2018 | en |
dc.identifier.citation | Gillessen S, Schmid S, Beltran H, Almeida DVP, Mehra N, Lavaud P, et al. 814P Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: a multicentre retrospective analysis. Ann Oncol. 2018;29(suppl_8):282. | en |
dc.identifier.doi | 10.1093/annonc/mdy284.023 | en |
dc.identifier.uri | http://hdl.handle.net/10541/621804 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1093/annonc/mdy284.023 | en |
dc.title | Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: a multicentre retrospective analysis | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK | en |
dc.identifier.journal | Annals of Oncology | en |
dc.description.note | en] | |
refterms.dateFOA | 2020-04-20T10:40:46Z |